Recent Finacing
Recent Raise
Pennsylvania biotech Ophidion develops OCCT, a Trojan-horse receptor-mediated IV transport platform delivering small molecules and macromolecules across the blood–brain barrier for gene-silencing in Huntington’s, Alzheimer’s, Parkinson’s.
